Phagenesis
Latest round
- Series D
Last raised
- Mar 2024
Total raised
- $59M
Investors
- 6
About Phagenesis
Founded in 2007 and based in Manchester, UK, Phagenesis Limited operates as a private healthcare company focused on developing treatments for dysphagia, specifically neurogenic dysphagia. The company offers Phagenyx® Neurostimulation System, this device is used for the treatment of dysphagia, a medical term for patients with difficulty in swallowing. This system features a dual-function catheter capable of both delivering stimulation and feeding, tailored to individual patient needs. The therapy aims to restore neurological control over swallowing.
Who invested in Phagenesis
6 investors across 3 rounds
See all investors in Phagenesis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Phagenesis
Who invested in Phagenesis?
Phagenesis has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Phagenesis raised?
Phagenesis has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Phagenesis last raise money?
Phagenesis's most recent round on record is a Series D, in Mar 2024.
What does Phagenesis do?
Founded in 2007 and based in Manchester, UK, Phagenesis Limited operates as a private healthcare company focused on developing treatments for dysphagia, specifically neurogenic dysphagia.
Where is Phagenesis headquartered?
Phagenesis is headquartered in Manchester, UK.
Which VCs invest in companies like Phagenesis?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Phagenesis's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Phagenesis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.